Skip to content

Circulating cytokines and gene expression in patients with endocrine and metabolic diseases

Circulating cytokines and gene expression in patients with endocrine and metabolic diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010719
Enrollment
Unknown
Registered
2017-02-23
Start date
2017-03-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endocrine and metabolic diseases

Interventions

Sponsors

Xinqiao Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 18-70 years, from January 2017 to December 2017 in our hospital outpatient department of endocrinology; (2) the endocrine and metabolic disease diagnosis according to relevant clinical diagnostic criteria, such as the diagnostic criteria for diabetes using the diagnostic criteria of WHO in 1999, GAD and IAA antibodies to screening except type 1 diabetes; obesity at 2000 WHO in the Western Pacific working group to develop the diagnostic criteria of obesity; (3) according to the corresponding clinical diagnosis standard of endocrine and metabolic diseases associated with complications, such as the use of urinary albumin creatinine ratio, fundus fluorescein angiography and ultrasound diagnosis of diabetic nephropathy, diabetic retinopathy and diabetic angiopathy; (4) no hypertension, coronary heart disease, cerebral infarction and other vascular related chronic diseases; (5) who had not been taking steroids for 3 months; (6) recently did not occur in acute diabetic complications such as diabetic ketoacidosis, no serious liver and kidney dysfunction; (7) tissue samples were collected from patients who underwent surgical treatment for chronic cholecystitis, fracture internal fixation, or liver or thyroid disease.

Exclusion criteria

Exclusion criteria: (1) minors; (2) pregnant and lactating women; (3) white blood cell was higher than normal value.

Design outcomes

Primary

MeasureTime frame
Glucose;cytokine;

Secondary

MeasureTime frame
Insulin;lipid profiles;

Countries

China

Contacts

Public ContactHongting Zheng

Xinqiao Hospital, Third Military Medical University

fnf7703@hotmail.com+86 023-68755709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026